| - GRCh37:
- Chr5:89979953-89979954
- GRCh38:
- Chr5:90684136-90684137
| ADGRV1 | E2077fs | Usher syndrome | Likely pathogenic (Mar 9, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr10:73405599
- GRCh38:
- Chr10:71645842
| CDH23 | S384R | Usher syndrome | Pathogenic (Mar 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216538381
- GRCh38:
- Chr1:216365039
| USH2A | D233fs | Usher syndrome | Likely pathogenic (Mar 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216538375-216538376
- GRCh38:
- Chr1:216365033-216365034
| USH2A | T235fs | Usher syndrome | Likely pathogenic (Mar 20, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216258063
- GRCh38:
- Chr1:216084721
| USH2A, USH2A-AS2 | E1715G | Usher syndrome | Likely pathogenic (Feb 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216373464-216390728
| USH2A | | Usher syndrome | Likely pathogenic (Feb 22, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:89940688
- GRCh38:
- Chr5:90644871
| ADGRV1 | | Usher syndrome | Likely pathogenic (Feb 21, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr9:117266707
- GRCh38:
- Chr9:114504427
| WHRN | A126fs | Usher syndrome | Likely pathogenic (Feb 20, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90077320
- GRCh38:
- Chr5:90781503
| ADGRV1 | V4386fs | Usher syndrome | Likely pathogenic (Feb 19, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr10:73571349
- GRCh38:
- Chr10:71811592
| CDH23 | | Usher syndrome | Likely pathogenic (Feb 27, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215853573-215853574
- GRCh38:
- Chr1:215680231-215680232
| USH2A | N4071fs | Usher syndrome | Likely pathogenic (Jan 11, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215963625-216107957
| USH2A | | Usher syndrome | Likely pathogenic (Jan 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:72916324
- GRCh38:
- Chr17:74920229
| USH1G | Q100*, Q203* | Usher syndrome | Likely pathogenic (Jan 21, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90078980-90078987
- GRCh38:
- Chr5:90783163-90783170
| ADGRV1 | L4425fs | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Dec 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216073530-216073531
- GRCh38:
- Chr1:215900188-215900189
| USH2A | S2494fs | Usher syndrome | Likely pathogenic (Dec 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90021387
- GRCh38:
- Chr5:90725570
| ADGRV1 | E3359* | Usher syndrome | Likely pathogenic (Dec 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90449059
- GRCh38:
- Chr5:91153242
| ADGRV1 | A6216fs | Usher syndrome | Likely pathogenic (Nov 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90136803-90261231
| ADGRV1 | | Usher syndrome | Likely pathogenic (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:89986685
- GRCh38:
- Chr5:90690868
| ADGRV1 | R2260* | Usher syndrome | Likely pathogenic (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:89914999-89968362
| ADGRV1 | | Usher syndrome | Likely pathogenic (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90111554
- GRCh38:
- Chr5:90815737
| ADGRV1 | | Usher syndrome | Likely pathogenic (May 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215844431-215844437
- GRCh38:
- Chr1:215671089-215671095
| USH2A | E4671fs | Usher syndrome | Likely pathogenic (Apr 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:73454017-73468962
| CDH23 | | Usher syndrome | Likely pathogenic (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216369929
- GRCh38:
- Chr1:216196587
| USH2A, USH2A-AS1 | S1406* | Usher syndrome, not provided | Pathogenic (Nov 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215813982-215813983
- GRCh38:
- Chr1:215640640-215640641
| USH2A | E4963fs | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Nov 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215990469
- GRCh38:
- Chr1:215817127
| USH2A | W3147* | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Apr 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216062129
- GRCh38:
- Chr1:215888787
| USH2A | P2621fs | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Feb 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216373234
- GRCh38:
- Chr1:216199892
| USH2A, USH2A-AS1 | Y1182* | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Apr 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:89979676-89979677
- GRCh38:
- Chr5:90683859-90683860
| ADGRV1 | S1982fs | not provided, Usher syndrome | Pathogenic/Likely pathogenic (Jun 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216462753-216495224
| USH2A | | Usher syndrome | Pathogenic (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:73544680
- GRCh38:
- Chr10:71784923
| CDH23 | N1845K | Usher syndrome | Pathogenic (Feb 12, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr10:73405588-73406374
| CDH23 | | Usher syndrome | not provided | no assertion provided |
| - GRCh37:
- Chr17:72916429
- GRCh38:
- Chr17:74920334
| USH1G | E168*, E65* | Usher syndrome | Likely pathogenic (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:150690306
- GRCh38:
- Chr3:150972519
| CLRN1 | G64R | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:90150019-90159573
| ADGRV1 | | Usher syndrome | Likely pathogenic (Nov 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:89988604-90077246
| ADGRV1 | | Usher syndrome | Likely pathogenic (Nov 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:89988600
- GRCh38:
- Chr5:90692783
| ADGRV1 | R2377Q | not specified, not provided | Conflicting interpretations of pathogenicity (Jan 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:216462705
- GRCh38:
- Chr1:216289363
| USH2A | A630fs | Usher syndrome | Likely pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:215812582
- GRCh38:
- Chr1:215639240
| USH2A | | Usher syndrome | Likely pathogenic (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216011333-216040512
| USH2A | | Usher syndrome | Likely pathogenic (Jun 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:90020647
- GRCh38:
- Chr5:90724830
| ADGRV1 | | not provided, Usher syndrome, Febrile seizures, familial, 4
| Pathogenic/Likely pathogenic (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:73539134-73539135
- GRCh38:
- Chr10:71779377-71779378
| CDH23 | H1769fs | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Mar 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216369894
- GRCh38:
- Chr1:216196552
| USH2A-AS1, USH2A | | Usher syndrome, not provided, Retinitis pigmentosa 39
| Pathogenic/Likely pathogenic (Jan 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:73565755
- GRCh38:
- Chr10:71805998
| CDH23, LOC111982869 | | not provided, Usher syndrome | Likely pathogenic (Dec 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215916678
- GRCh38:
- Chr1:215743336
| USH2A | | not provided | Likely pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216107957
- GRCh38:
- Chr1:215934615
| USH2A | | Usher syndrome, not provided | Likely pathogenic (Mar 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:89986637
- GRCh38:
- Chr5:90690820
| ADGRV1 | V2244I | Febrile seizures, familial, 4, Usher syndrome type 2C, Usher syndrome, not provided | Uncertain significance (Jun 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:31353860
- GRCh38:
- Chr14:30884654
| COCH, LOC100506071 | T244I, T309I | Usher syndrome | Uncertain significance (Apr 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:71190407
- GRCh38:
- Chr2:70963277
| ATP6V1B1 | I342S | Usher syndrome | Uncertain significance (Apr 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216370022
- GRCh38:
- Chr1:216196680
| USH2A, USH2A-AS1 | S1375L | Usher syndrome, not provided, Retinitis pigmentosa 39
| Conflicting interpretations of pathogenicity (Feb 17, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:216500943
- GRCh38:
- Chr1:216327601
| USH2A | L280F | not provided, Usher syndrome | Pathogenic/Likely pathogenic (Dec 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:150690308
- GRCh38:
- Chr3:150972521
| CLRN1 | Y63S | Usher syndrome type 3A, Usher syndrome | Pathogenic/Likely pathogenic (Feb 12, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr1:216497696
- GRCh38:
- Chr1:216324354
| USH2A | | Usher syndrome, not provided, Usher syndrome type 2A, Retinitis pigmentosa 39 | Pathogenic (Mar 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:48337729
- GRCh38:
- Chr19:47834472
| CRX | H10R | Usher syndrome | Uncertain significance (Jun 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:73375337
- GRCh38:
- Chr10:71615580
| CDH23 | L305fs | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:73405588-73406374
| CDH23 | | Usher syndrome | Likely pathogenic (Mar 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:76883787-76883796
- GRCh38:
- Chr11:77172741-77172750
| MYO7A | | Usher syndrome, not provided, Usher syndrome type 1
| Pathogenic/Likely pathogenic (Jun 18, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:90124827
- GRCh38:
- Chr5:90829010
| ADGRV1 | N5479fs | not provided, Retinal dystrophy, Usher syndrome
| Pathogenic/Likely pathogenic (Feb 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:90074268-90074269
- GRCh38:
- Chr5:90778451-90778452
| ADGRV1 | S4233fs | Usher syndrome, Retinal dystrophy, not provided
| Pathogenic/Likely pathogenic (Dec 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216270451
- GRCh38:
- Chr1:216097109
| USH2A | R1578C | Retinitis pigmentosa 39, Usher syndrome, not provided
| Pathogenic/Likely pathogenic (Aug 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215963509
- GRCh38:
- Chr1:215790167
| USH2A | C3358* | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Jan 19, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:55591299
- GRCh38:
- Chr10:53831539
| PCDH15 | | not provided | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:216138703-216138704
- GRCh38:
- Chr1:215965361-215965362
| USH2A | L2359fs | Usher syndrome, not provided | Pathogenic/Likely pathogenic (Mar 31, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:78403608
- GRCh38:
- Chr15:78111266
| CIB2 | R33* | Usher syndrome, not provided | Pathogenic (Feb 19, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215808017-215808035
- GRCh38:
- Chr1:215634675-215634693
| USH2A | T5022fs | Usher syndrome, Retinal dystrophy, Usher syndrome type 2, not provided | Pathogenic/Likely pathogenic (Jul 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216420440
- GRCh38:
- Chr1:216247098
| USH2A | C766R | Usher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39, Retinal dystrophy, not provided, Retinitis pigmentosa
| Pathogenic/Likely pathogenic (Mar 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216258195
- Chr1:215848805
- GRCh38:
- Chr1:216084853
- Chr1:215675463
| USH2A, USH2A-AS2, USH2A | G1671D, T4150A | Retinitis pigmentosa | Likely pathogenic (Jun 23, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr1:216108091
- GRCh38:
- Chr1:215934749
| USH2A | | Usher syndrome | Likely benign (May 26, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr10:55955581
- GRCh38:
- Chr10:54195821
| PCDH15 | N352fs, N389fs, N394fs, N367fs | Usher syndrome | Likely pathogenic (Jan 22, 2019) | criteria provided, single submitter |
| | USH2A | | Usher syndrome | Likely pathogenic (Apr 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr1:216052410
- GRCh38:
- Chr1:215879068
| USH2A | G2752R | Usher syndrome, Retinal dystrophy, not provided, Usher syndrome type 2A | Pathogenic/Likely pathogenic (Mar 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:90086961
- GRCh38:
- Chr5:90791144
| ADGRV1 | S4772* | Usher syndrome | Pathogenic (Dec 13, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr5:140057489-140057494
- GRCh38:
- Chr5:140677904-140677909
| HARS1 | | Usher syndrome | Uncertain significance (Aug 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:34085704
- GRCh38:
- Chr20:35497875
| CEP250 | R1155*, R523* | Cone-rod dystrophy and hearing loss 2 | Likely pathogenic (Feb 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:73550922
- GRCh38:
- Chr10:71791165
| CDH23 | D2028A | not provided, Usher syndrome | Pathogenic/Likely pathogenic (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:66303767
- GRCh38:
- Chr17:68307626
| ARSG | D45Y | Usher syndrome, type 4, Usher syndrome | Pathogenic (Aug 3, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr1:216166445
- GRCh38:
- Chr1:215993103
| USH2A | P2241L | Retinitis pigmentosa, Usher syndrome, not provided, Retinitis pigmentosa 39 | Pathogenic/Likely pathogenic (Nov 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216371836
- Chr1:215802356
- GRCh38:
- Chr1:216198494
- Chr1:215629014
| USH2A, USH2A-AS1, USH2A | G1301V, P5107S | Retinitis pigmentosa 39 | Uncertain significance (Sep 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr1:216420437
- Chr1:216270469
- GRCh38:
- Chr1:216247095
- Chr1:216097127
| USH2A, USH2A | E767fs, L1572F | Usher syndrome type 2A | Pathogenic (Sep 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:15992840
- GRCh38:
- Chr4:15991217
| PROM1 | | Usher syndrome | Uncertain significance (Sep 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:16002235
- GRCh38:
- Chr4:16000612
| PROM1 | G488*, G479* | Usher syndrome | Pathogenic (Sep 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr1:216420126
- GRCh38:
- Chr1:216246784
| LOC122152296, USH2A | C870* | Retinal dystrophy, not provided, Rare genetic deafness, Usher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39, Usher syndrome type 2A | Pathogenic (Feb 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:76885863
- GRCh38:
- Chr11:77174817
| MYO7A | R666Q, R655Q | Usher syndrome | Uncertain significance (May 20, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr1:216251604
- GRCh38:
- Chr1:216078262
| USH2A, USH2A-AS2 | W1800* | Usher syndrome, Retinal dystrophy, Usher syndrome type 2A, Retinitis pigmentosa 39, not provided, Usher syndrome type 2A
| Pathogenic (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215848036
- GRCh38:
- Chr1:215674694
| USH2A | L4406P | Usher syndrome | Uncertain significance (May 20, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr1:215990440
- GRCh38:
- Chr1:215817098
| USH2A | Q3157* | Retinitis pigmentosa 39, Usher syndrome type 2A, not provided, Usher syndrome | Pathogenic (Oct 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215901607
- GRCh38:
- Chr1:215728265
| USH2A | A3944D | Usher syndrome type 2A, Retinitis pigmentosa 39, Usher syndrome
| Likely pathogenic (May 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216595636
- GRCh38:
- Chr1:216422294
| USH2A | Q15* | not provided, Usher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39 | Pathogenic/Likely pathogenic (Feb 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216144022
- GRCh38:
- Chr1:215970680
| USH2A | L2301S | Usher syndrome, Retinal dystrophy, not provided, Usher syndrome type 2A, Retinitis pigmentosa 39 | Conflicting interpretations of pathogenicity (Jun 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:216591969
- GRCh38:
- Chr1:216418627
| USH2A | S180P | Retinitis pigmentosa 39, Usher syndrome type 2A, Usher syndrome, not provided | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:216591855
- GRCh38:
- Chr1:216418513
| USH2A | | Retinitis pigmentosa 39, Usher syndrome type 2A, Usher syndrome, not provided | Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:215812532
- GRCh38:
- Chr1:215639190
| USH2A | T5006M | Retinitis pigmentosa 39, Usher syndrome type 2A, not provided, Usher syndrome, Usher syndrome type 2A, Retinal dystrophy
| Pathogenic/Likely pathogenic (Jul 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216595439-216595440
- GRCh38:
- Chr1:216422097-216422098
| USH2A | Q81fs | not provided, Usher syndrome, Retinitis pigmentosa 39, Usher syndrome type 2A | Pathogenic (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216496816
- GRCh38:
- Chr1:216323474
| USH2A | R517T | Retinal dystrophy, not provided, Usher syndrome, Retinitis pigmentosa 39, Usher syndrome type 2A | Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:216424240
- GRCh38:
- Chr1:216250898
| USH2A | | not provided, Usher syndrome, Retinal dystrophy, Retinitis pigmentosa 39, Usher syndrome type 2A, Retinitis pigmentosa 39
| Pathogenic/Likely pathogenic (Jan 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216348605
- GRCh38:
- Chr1:216175263
| USH2A | T1539I | Usher syndrome, Retinal dystrophy, Usher syndrome type 2A, not provided | Conflicting interpretations of pathogenicity (Apr 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:216462734
- GRCh38:
- Chr1:216289392
| USH2A | C620F | Usher syndrome | Likely pathogenic (Feb 25, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr1:215932085
- GRCh38:
- Chr1:215758743
| USH2A | Y3747* | Usher syndrome | Pathogenic (Sep 17, 2018) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr1:215821999
- GRCh38:
- Chr1:215648657
| USH2A | P4818L | Usher syndrome type 2A, Retinitis pigmentosa 39, Rare genetic deafness, Usher syndrome, Usher syndrome type 2A, Retinitis pigmentosa 39, not provided | Pathogenic/Likely pathogenic (Feb 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:216011333-216270555
| USH2A | | Usher syndrome | Pathogenic (Mar 7, 2018) | criteria provided, single submitter |